{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:36:38Z","timestamp":1792679798736,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.nrleng.2024.07.004","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:16:32Z","timestamp":1725272192000},"page":"573-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Circulating microRNAs as potential biomarkers for the diagnosis of Parkinson's disease: A meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"W.T.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.F.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.N.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.S.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2024.07.004_bib0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","article-title":"Epidemiology of Parkinson's disease","volume":"172","author":"Elbaz","year":"2016","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/NHH.0000000000000398","article-title":"Parkinson disease","volume":"34","author":"Capriotti","year":"2016","journal-title":"Home Healthc Now"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0185","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0190","doi-asserted-by":"crossref","first-page":"631553","DOI":"10.3389\/fnmol.2021.631553","article-title":"Circulating microRNAs and long non-coding RNAs as potential diagnostic biomarkers for Parkinson's disease","volume":"14","author":"Yang","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0195","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3389\/fneur.2019.01285","article-title":"Diffusion kurtosis imaging for detection of early brain changes in Parkinson's disease","volume":"10","author":"Guan","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/2211536607666180827111633","article-title":"MiRNAs: biology, biogenesis, their web-based tools, and databases","volume":"8","author":"Tafrihi","year":"2019","journal-title":"MicroRNA"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0205","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00221-017-4989-1","article-title":"MicroRNAs in Parkinson's disease","volume":"235","author":"Singh","year":"2017","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0210","doi-asserted-by":"crossref","first-page":"101732","DOI":"10.1016\/j.pneurobio.2019.101732","article-title":"Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders","volume":"185","author":"van den Berg","year":"2020","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0215","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson's disease: biomarkers, treatment, and risk factors","volume":"12","author":"Emamzadeh","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0220","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","article-title":"MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson's disease","volume":"9","author":"Chen","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0225","first-page":"294","article-title":"Expressions and clinical significance of miR-124 and miR-494 in elderly patients with Parkinson disease","volume":"30","author":"Li","year":"2021","journal-title":"Chin J Behav Med Brain Sci"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0235","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0240","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fneur.2018.00156","article-title":"Diagnostic criteria for Parkinson's disease: from James Parkinson to the concept of prodromal disease","volume":"9","author":"Marsili","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0245","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0250","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0255","first-page":"72","article-title":"The diagnostic efficacy of serum miR-103a, miR-30b, miR-29a relative expression levels for Parkinson's disease","volume":"57","author":"Han","year":"2017","journal-title":"J Shandong Med"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0260","first-page":"206","article-title":"The expression of serum microRNA-221 and microRNA-214 in Parkinson's disease and its correlation with Parkinson's comprehensive score","volume":"55","author":"Zhou","year":"2020","journal-title":"Chin Med J"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JPD-012144","article-title":"Plasma-based circulating microRNA biomarkers for Parkinson's disease","volume":"2","author":"Khoo","year":"2012","journal-title":"J Parkinson's Dis"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0270","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jnr.23377","article-title":"Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease","volume":"92","author":"Botta-Orfila","year":"2014","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0275","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","article-title":"Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease","volume":"22","author":"Ding","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/1354750X.2015.1118544","article-title":"A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease","volume":"21","author":"Dong","year":"2016","journal-title":"Biomarkers"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0285","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","article-title":"MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles","volume":"644","author":"Cao","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0290","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10072-017-2841-9","article-title":"Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression","volume":"38","author":"Li","year":"2017","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0295","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-017-0316-0","article-title":"Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases","volume":"9","author":"Sheinerman","year":"2017","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0300","first-page":"1857","article-title":"Serum miR-9a and miR-133b, diagnostic markers for Parkinson's disease, are up-regulated after levodopa treatment","volume":"36","author":"Wu","year":"2020","journal-title":"Acta Med Mediterranea"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0305","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1038\/s41598-021-94734-z","article-title":"Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0310","doi-asserted-by":"crossref","first-page":"700959","DOI":"10.3389\/fnagi.2021.700959","article-title":"Serum miR-214 serves as a biomarker for prodromal Parkinson's disease","volume":"13","author":"Li","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0315","article-title":"Diagnostic performance of miR-485-3p in patients with Parkinson's disease and its relationship with neuroinflammation","author":"Lin","year":"2021","journal-title":"Neuromol Med"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0320","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/00207454.2020.1784165","article-title":"Serum microRNA expression levels in Turkish patients with Parkinson's disease","volume":"131","author":"Ozdilek","year":"2021","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0330","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0335","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/bmj.329.7458.168","article-title":"Diagnostic tests 4: likelihood ratios","volume":"329","author":"Deeks","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.nrleng.2024.07.004_bib0340","article-title":"The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: a meta-analysis","author":"Zhang","year":"2021","journal-title":"Neurologia"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580824000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580824000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:17:09Z","timestamp":1725272229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580824000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2173580824000671"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2024.07.004","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microRNAs as potential biomarkers for the diagnosis of Parkinson's disease: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2024.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}